Nuvation Bio Inc.
NUVB
$4.39
-$0.12-2.56%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -204.63M | -217.48M | -202.90M | -606.38M | -567.94M |
| Total Depreciation and Amortization | 1.74M | 1.42M | 1.05M | 935.00K | 683.00K |
| Total Amortization of Deferred Charges | 662.00K | 335.00K | 18.00K | -- | -- |
| Total Other Non-Cash Items | 40.78M | 38.18M | 32.46M | 453.25M | 449.35M |
| Change in Net Operating Assets | -11.98M | -12.45M | 1.18M | -5.14M | -12.51M |
| Cash from Operations | -173.43M | -190.00M | -168.19M | -157.34M | -130.41M |
| Capital Expenditure | -354.00K | -252.00K | -388.00K | -207.00K | -162.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -92.00K | -92.00K | 12.43M | 12.43M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 99.87M | 64.55M | 190.43M | 157.12M | 110.44M |
| Cash from Investing | 99.52M | 64.21M | 189.95M | 169.34M | 122.70M |
| Total Debt Issued | 210.10M | 204.48M | 204.48M | 12.61M | 12.61M |
| Total Debt Repaid | -12.39M | -8.40M | -11.54M | -17.70M | -17.16M |
| Issuance of Common Stock | 11.42M | 4.09M | 5.21M | 5.95M | 4.89M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.60M | -6.60M | -6.61M | -- | -- |
| Cash from Financing | 202.54M | 193.57M | 191.53M | 858.00K | 331.00K |
| Foreign Exchange rate Adjustments | -265.00K | 1.08M | 398.00K | 604.00K | 453.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 128.36M | 68.86M | 213.69M | 13.47M | -6.93M |